Skip to main content
logo
Botanix Pharmaceuticals Limited (ASX:BOT)
Australia flag Australia · Delayed Price · Currency is AUD
0.0200
+0.0010 (5.26%)
Sep 11, 2026, 11:24 AM AEST

Botanix Pharmaceuticals Financials Overview

Millions AUD. Fiscal year is Jul - Jun.

Revenue & Profits
Chart
Fiscal YearTTMFY 2026FY 2025FY 2024FY 2023FY 2022
Period EndingJun '26 Jun '26 Jun '25 Jun '24 Jun '23 Jun '22
Revenue
33.833.85.792.073.772.75
Revenue Growth
54.22%483.87%179.74%-45.14%36.94%-60.00%
Gross Profit
19.4519.452.02-1.58-1.96-7.54
Operating Income
-69.31-69.31-82.91-13.99-9.13-13.19
Net Income
-69.77-69.77-86.4-13.87-9.15-13.17
Earnings Per Share
-0.03-0.03-0.05-0.01-0.01-0.01
EPS Growth
------

Cash & Debt
Chart
Fiscal YearCurrentFY 2026FY 2025FY 2024FY 2023FY 2022
Period EndingJun '26 Jun '26 Jun '25 Jun '24 Jun '23 Jun '22
Cash & Investments
36.6336.6364.9779.3110.257.29
Total Debt
0.920.921.22--0.12
Net Cash (Debt)
35.7135.7163.7579.3110.257.16
Net Cash Growth
16.97%-43.98%-19.62%673.71%43.10%-66.36%
Net Cash Per Share
0.020.020.030.050.010.01

Cash Flow & CapEx
Chart
Fiscal YearTTMFY 2026FY 2025FY 2024FY 2023FY 2022
Period EndingJun '26 Jun '26 Jun '25 Jun '24 Jun '23 Jun '22
Operating Cash Flow
-64.6-64.6-78.58-8.13-12.07-11.18
Capital Expenditures
---0.29-0.11-0.01-0.01
Free Cash Flow
-64.6-64.6-78.87-8.24-12.08-11.19
Free Cash Flow Growth
------

Margins
Chart
Fiscal YearTTMFY 2026FY 2025FY 2024FY 2023FY 2022
Period EndingJun '26 Jun '26 Jun '25 Jun '24 Jun '23 Jun '22
Gross Margin
57.55%57.55%34.85%-76.48%-51.83%-273.62%
Operating Margin
-205.05%-205.05%-1432.24%-676.11%-241.93%-478.66%
Pretax Margin
-206.41%-206.41%-1492.37%-670.20%-242.66%-478.10%
Profit Margin
-206.41%-206.41%-1492.37%-670.20%-242.66%-478.10%
FCF Margin
-191.10%-191.10%-1362.39%-398.17%-320.27%-406.24%

Valuation
Chart
Fiscal YearCurrentFY 2026FY 2025FY 2024FY 2023FY 2022
Period EndingSep '26 Jun '26 Jun '25 Jun '24 Jun '23 Jun '22
Forward PE
-86.0086.0069.006.256.25
PS Ratio
1.541.54108.40301.7545.2320.14